Trademark: JUNOVAN 1104784
Word
JUNOVAN
ID
1104784
Trademark Type
Word
Status
Ceased
Not renewed: Renewal fee not paid
Not renewed: Renewal fee not paid
Application Date
13 September 2005
Registration Date
13 September 2005
Owner(s)
Service
Refer to WIPO address for Correspondence
Goods and Services:
Class 5:
Chemical products for preparations for medical or veterinary use, particularly muramyl peptides and muramyl tripeptides, muramyl tripeptide phosphatidyl ethanolamine (MTP-PE), N-acetylmuramyl-L-ananyl-D-isoglutaminyl-L-alanine-2 (l,2-dipalmitoyl-sn-glycero-3-hydroxyphosphoryloxy) ethylamide, hexopyranose and formulations of muramyl peptides, particularly liposomal formulations, pharmaceutically acceptable forms of muramyl peptides, pharmaceutically acceptable salts of muramyl peptides, all these goods specifically used for cancer control treatment, antiviral treatment, neoplasia and chemotherapy-induced pathologies, particularly mucositis, myelosuppression, peripheral neuropathy; pharmaceutical preparations, particularly for cancer control and antiviral treatments, neoplasia and chemotherapy-induced pathologies, particularly mucositis, myelosuppression, peripheral neuropathy
Chemical products for preparations for medical or veterinary use, particularly muramyl peptides and muramyl tripeptides, muramyl tripeptide phosphatidyl ethanolamine (MTP-PE), N-acetylmuramyl-L-ananyl-D-isoglutaminyl-L-alanine-2 (l,2-dipalmitoyl-sn-glycero-3-hydroxyphosphoryloxy) ethylamide, hexopyranose and formulations of muramyl peptides, particularly liposomal formulations, pharmaceutically acceptable forms of muramyl peptides, pharmaceutically acceptable salts of muramyl peptides, all these goods specifically used for cancer control treatment, antiviral treatment, neoplasia and chemotherapy-induced pathologies, particularly mucositis, myelosuppression, peripheral neuropathy; pharmaceutical preparations, particularly for cancer control and antiviral treatments, neoplasia and chemotherapy-induced pathologies, particularly mucositis, myelosuppression, peripheral neuropathy